131 related articles for article (PubMed ID: 19710244)
1. Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research.
Rahman NA; Rao CV
Mol Hum Reprod; 2009 Nov; 15(11):703-11. PubMed ID: 19710244
[TBL] [Abstract][Full Text] [Related]
2. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility.
Filicori M; Fazleabas AT; Huhtaniemi I; Licht P; Rao ChV; Tesarik J; Zygmunt M
Fertil Steril; 2005 Aug; 84(2):275-84. PubMed ID: 16084861
[TBL] [Abstract][Full Text] [Related]
3. Nongonadal LH receptors, their involvement in female reproductive function and a new applicable approach.
Ziecik AJ; Bodek G; Blitek A; Kaczmarek M; Waclawik A
Vet J; 2005 Jan; 169(1):75-84. PubMed ID: 15683766
[TBL] [Abstract][Full Text] [Related]
4. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine.
Rao CV; Lei ZM
Mol Cell Endocrinol; 2007 Apr; 269(1-2):2-8. PubMed ID: 17382462
[TBL] [Abstract][Full Text] [Related]
5. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.
Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887
[TBL] [Abstract][Full Text] [Related]
6. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
[TBL] [Abstract][Full Text] [Related]
7. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
8. Change, change, change: hormonal actions depend on changes in blood levels.
Kol S; Homburg R
Hum Reprod; 2008 May; 23(5):1004-6. PubMed ID: 18326517
[TBL] [Abstract][Full Text] [Related]
9. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor.
van de Lagemaat R; Timmers CM; Kelder J; van Koppen C; Mosselman S; Hanssen RG
Hum Reprod; 2009 Mar; 24(3):640-8. PubMed ID: 19088107
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic induction of ovulation: towards the replacement of hCG with LH].
Emperaire JC
Contracept Fertil Sex; 1994; 22(7-8):459-67. PubMed ID: 7920947
[TBL] [Abstract][Full Text] [Related]
11. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
12. Treatment with human chorionic gonadotropin (hCG) for ovulation induction is associated with an immediate 17beta-estradiol decrease and a more rapid LH increase in mares.
Ginther OJ; Beg MA; Gastal EL; Gastal MO; Cooper DA
Anim Reprod Sci; 2009 Aug; 114(1-3):311-7. PubMed ID: 18835670
[TBL] [Abstract][Full Text] [Related]
13. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
[TBL] [Abstract][Full Text] [Related]
14. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
Baer G; Loumaye E
Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of hormone action: luteinizing hormone receptors and second-messenger pathways.
Davis JS
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):254-61. PubMed ID: 8038413
[TBL] [Abstract][Full Text] [Related]
16. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.
Choi J; Smitz J
Gynecol Endocrinol; 2014 Mar; 30(3):174-81. PubMed ID: 24283620
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of complimentarity between monoclonal antibodies (MAbs) to human chorionic gonadotropin (hCG) and polyclonal antibodies to luteinizing hormone/hCG receptor (LH-R) and their use in better understanding hormone-receptor interaction.
Jeyakumar M; Krishnamurthy HN; Dighe RR; Moudgal NR
Recept Signal Transduct; 1997; 7(4):299-310. PubMed ID: 9633830
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
20. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation?
Perrier d'Hauterive S; Berndt S; Tsampalas M; Charlet-Renard C; Dubois M; Bourgain C; Hazout A; Foidart JM; Geenen V
Gynecol Obstet Invest; 2007; 64(3):156-60. PubMed ID: 17934312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
